| JXSL2400039 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-06 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2500128 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-07-25 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JTS2200102 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2300048 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2023-08-30 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JXSL2500131 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-07-25 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2400040 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-06 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2400037 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-06 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2400036 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-06 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2500130 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-07-25 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2400009 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.1) | Import Drug Application | 2024-01-10 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2500127 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-07-25 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JTS2200100 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JXSL2400038 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-02-06 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JXSL2500129 | Risankizumab注射液 | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-07-25 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Inc | | | view |
| JTS2200101 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2300061 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2023-11-16 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;AbbVie Biotechnology Ltd;Abbvie Inc | | | view |
| JXSB2500069 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Supplementary Application | 2025-07-22 | | AbbVie Biotechnology Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2000054 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2021-05-09 | view |
| JXSB2300061 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2000055 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2021-05-09 | view |
